Fusion Pharmaceuticals Inc.

NasdaqGS:FUSN Stock Report

Market Cap: US$1.8b

Fusion Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of FUSN?
Owner TypeNumber of SharesOwnership Percentage
Private Companies5080.000597%
Individual Insiders499,1630.587%
Public Companies3,256,9723.83%
VC/PE Firms6,825,3958.02%
General Public7,907,9079.3%
Hedge Funds12,901,32815.2%
Institutions53,668,69263.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.2%.


Top Shareholders

Top 25 shareholders own 79.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.7%
Federated Hermes, Inc.
10,811,153US$233.0m-0.69%0.61%
8.02%
Perceptive Advisors LLC
6,825,395US$147.1m148%2.98%
7.64%
Avidity Partners Management, L.P.
6,500,328US$140.1m0%5.41%
7.53%
Deerfield Management Company, L.P. Series C
6,401,000US$137.9m0%2.63%
4.92%
Fidelity International Ltd
4,187,271US$90.2m0%0.04%
4.48%
Odlander, Fredrikson & Co. AB
3,807,247US$82.0m0%27.68%
4.45%
Pentwater Capital Management LP
3,781,778US$81.5m0%2.23%
4.32%
Johnson & Johnson Innovation - JJDC, Inc.
3,670,516US$79.1m0%17.26%
3.83%
Siemens Aktiengesellschaft
3,256,972US$70.2m0%no data
3.66%
Canada Pension Plan Investment Board
3,116,966US$67.2m0%0.04%
3%
TPG Capital, L.P.
2,551,794US$55.0m0%0.18%
2.16%
FMR LLC
1,836,739US$39.6m-65.4%no data
1.89%
Millennium Management LLC
1,608,882US$34.7m178%0.03%
1.76%
Marshall Wace LLP
1,501,283US$32.4m371%0.06%
1.18%
TIG Advisors, LLC
1,003,628US$21.6m0%3.08%
1.16%
Qube Research & Technologies Ltd
987,178US$21.3m0%0.04%
0.92%
William Blair Investment Management, LLC
779,202US$16.8m-21.6%0.02%
0.86%
1832 Asset Management L.P.
734,321US$15.8m0%0.02%
0.77%
Walleye Capital LLC
657,385US$14.2m162%0.1%
0.75%
Jane Street Group, LLC, Asset Management Arm
633,932US$13.7m2,150%0.02%
0.69%
JPMorgan Chase & Co, Brokerage and Securities Investments
589,725US$12.7m9,090%0.01%
0.69%
Alpine Associates Management Inc.
585,102US$12.6m0%0.65%
0.68%
Eagle Health Investments LP
579,769US$12.5m0%2.37%
0.66%
Pivotal BioVenture Partners LLC
563,385US$12.1m-63.9%5.39%
0.61%
BlackRock, Inc.
516,795US$11.1m23.1%no data